Going to #WCLC24? Lean more about LungOI the first AI-based multi gene NCSLC Biomarker Profiling Lab Developed Test clinically available through our CLIA Certified Lab. LungOI provides rapid next day results and can support timely informed clinical decisions. Addie Dvir our Head of Diagnostics will be there, DM to schedule a meeting. #NSCLC #BiomarkerTesting #LungCancer #PrecisionOncology
Imagene
Medical and Diagnostic Laboratories
Philadelphia , PA 7,077 followers
Immediate Oncology Intelligence
About us
Imagene was founded with a clear mission to leverage AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone. By doing so we can overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for all cancer patients. Imagene's technology classifies patterns that cannot be seen by the human eye, evolving genomics, proteomics, and spatial insights resulting in a fast and accurate molecular profiling. Our technology also enables better stratification of patients for clinical trials and the discovery of novel targets for new drugs. We are a diverse startup with bright, passionate and most of all fun team. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide. The fight against cancer is profound and the world needs talented and innovative people - If you are looking for a meaningful and challenging job – Join Us!
- Website
-
https://imagene-ai.com
External link for Imagene
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 11-50 employees
- Headquarters
- Philadelphia , PA
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
2400 Market Street
No. 200
Philadelphia , PA 19103, US
-
Yitzhak Sadeh 17
Tel Aviv, IL
Employees at Imagene
-
Avital Rabani
B2B Marketer and Strategist, VP of Marketing @Imagene
-
Addie Dvir
Personalized medicine leader, Next generation AI image-based molecular analysis
-
Will Brown, MBA
Business & Commercial Operations Leader in Life Science, Pharma & Healthcare Technology. Adjunct Professor of Business & Entrepreneurship.
-
Yevhenia Dudnyk
Product Manager at Imagene AI
Updates
-
Imagene reposted this
Excited to be speaking at Oracle #CloudWorld2024 Join me for an insightful panel discussion: "Beyond the Hype - Real-World AI Solutions Scaling with Oracle Cloud Infrastructure." I’ll discuss the pivotal role of large-scale AI models in transforming cancer research and diagnostics. Mark Your Calendar: 📅 Wednesday, Sep. 11, 2024 🕘 Time: 9:45 AM - 10:30 AM PDT (7:45 PM - 8:30 PM IDT) 📍 Location: Bellini 2004, The Venetian, Level 2 If you're attending OCW, stop by and say hi 👋 Looking forward to connecting with you there! #CloudWorld2024 #OCW #AI #PrecisionOncology
-
-
Thank you Pathology Institute : Sheba Medical Center and Prof. Iris Barshack for highlighting the impact of AI in advancing cancer diagnostics. We're honored to be part of this important initiative. Together, we're advancing patient care by leveraging cutting-edge technology to accelerate diagnosis and treatment decisions.
“We have reached another significant milestone in digital pathology with this ability to detect biomarkers by AI. The use of deep learning algorithms is changing the world of diagnosis, and in certain cases can drastically shorten the cost and time to treatment. I am excited to hear about the growing number of patients who were able to receive rapid diagnoses and treatment using our new service.” - Prof. Iris Barshack, Head of the Pathology Institute at Sheba Medical Center, Tel Hashomer At the 2023 ARC Innovation Summit, Prof. Iris Barshack and Prof. Jason Hipp, MD,PhD of Mayo Clinic led a discussion on precision method with Alexander Sicular of Google, Jan Van Acker of MSD, dean bitan of Imagene, Tuvik Beker of Pangea Biomed, and Avi Veidman of Nucleai. Sharon Paz Chen Sagiv Boaz Brill https://lnkd.in/eWpkFB9c “AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment and outcomes. The platform enables the integration of AI technology developed by Sheba in addition to solutions created by innovative digital health start-ups. One of the first AI solutions to be deployed was developed by Imagene, an emerging leader in AI-based precision oncology, incorporating an algorithm to identify actionable biomarkers of non-small cell lung cancer. The algorithm is directly applied to a digitized image of a conventionally stained pathology slide and can then, within minutes, identify the presence of actionable biomarkers in the tumor, thus providing crucial information for diagnostic and therapeutic decisions. The solution essentially shortens diagnostic time from three weeks to minutes, enabling patients to begin treatment earlier.”
-
-
-
-
-
+2
-
-
"AI-based technology is slowly becoming interwoven within the everyday life and workflow of oncologists today." The revolution of AI within oncology is here. LungOI is the first AI-based Rapid Biomarker Profiling Laboratory Developed Test to identify actionable alterations in NSCLC patients. LungOI is a multi-gene biomarker test clinically available through our CLIA Certified Lab, providing test results in one day. DM us for more information on LungOI! #NSCLC #BiomarkerTesting #LungCancer #PrecisionMedicine #AIinHealthcare
"AI-based technology is slowly becoming interwoven within the everyday life and workflow of oncologists today." The revolution of AI within oncology is here. In a new editorial for ASCO Daily News, Dr. Matthew Kurian and Dr. Douglas Flora discuss how AI is already used in many diagnostic tools and stress the need to better understand these technologies in order to bring AI into everyday practice: https://lnkd.in/evhz4dvW
-
-
Today, on World Lung Cancer Day, we acknowledge the reality that lung cancer remains the deadliest form of cancer worldwide. Despite significant advancements in treatment, a critical gap remains: too many patients are not receiving the essential molecular testing needed to access life-saving targeted therapies. At Imagene, we are committed to closing this gap. We developed LungOI, the first AI-powered biomarker profiling test, to support timely and informed clinical decisions. Our goal is to increase access to these vital tests, ensuring that more patients can benefit from the advances in precision medicine. This day serves as a reminder of the work still ahead. By expanding access to molecular testing, we can help to make progress, and hopefully improve outcomes for patients everywhere. #PrecisionOncology #LungCancer #WorldLungCancerDay #NSCLC #biomarkertesting
-
-
Lung Cancer Research Foundation published a new guide: "You do not need to be a doctor to understand your tumor. Biomarker testing can help" LungOI the first AI-powered biomarker profiling test for NSCLC can support timely informed clinical decisions. A Laboratory Developed Test available through our CLIA certified lab. DM us to learn more.
Tumor testing to determine #biomarkers helps to determine the most effective treatment. Insist that your cancer is tested for the best outcomes. Learn more at LCRF.org/biomarkers. #lungcancer
-
-
A great educational session on "The Importance of Waiting for Biomarker Results in NSCLC" LungOI is the first AI-based Rapid Biomarker Profiling Laboratory Developed Test to identify actionable alterations in NSCLC patients. LungOI is a multi-gene biomarker test including alterations in genes EGFR, ALK, ROS1, RET, NTRK1/2/3, ERBB2, BRAF, and MET. Clinically available through our CLIA Certified Lab, providing same-day results. DM us for more information on LungOI! #NSCLC #BiomarkerTesting #LungCancer #PrecisionMedicine #AIinHealthcare https://lnkd.in/e3AkHCFf
-
A new article in Calcalist (Hebrew) telling the Imagene story and details our Oncology Intelligence: Vision Foundation Model Engine designed to decode cancer from biopsy images. This State-of-the-Art Foundation Model facilitates the development of unlimited downstream research applications beyond biomarker profiling, including predicting treatment responses, disease prognosis, and discovering novel biomarkers through the identification of pathological features. #foundationmodel #oncologyintelligence #OCI Oracle Cloud https://lnkd.in/e_QsFVxg
מצילים חיים: החברה שמצליחה לאבחן סרטן ריאות בתוך דקות בודדות | כלכליסט
calcalist.co.il
-
Thank you Rachel Dangur for acknowledging our talk. Indeed Imagene's Oncology Intelligence engine powered by Oracle holds the power to transform cancer diagnosis, research and care #precisiononcology #OCI #oncologyintelligence
I really enjoyed enriching my knowledge today at the future of AI Conference led by Ben Pelled, a leader in the FinTech and AI Conferences. We had the opportunity to get insights from AI leaders on optimizing innovation both internally and externally within organizations. I feel compelled to keep up with the rapid pace of that sector development, as I believe it's my duty, as well as that of every business development, sales, and innovation leader, to explore opportunities for enhancing organizational efficiency to achieve more success with fewer resourceses. Additionally, identifying avenues for implentation of innovative tools to meet business goals and increase revenue through additional tools is crucial. As part of my journey in learning about integrating AI in healthcare, it was fascinating to discover today the collaboration between Imagene and Oracle Cloud. As Imagene's VP of marketing director, Avital Rabani presented today, their mutual development of an "oncologic brain" that can not only diagnose mutations by learning millions of Biopsies exams, but also answer complex questions like treatment responsiveness, patient profile matching for clinical trials, and more. This promises will be creating accessibility, saving resources and time for numerous researchers and physicians. I am truly curious to see how I, along with other industry leaders in healthcare, can realize these opportunities and turn them from vision into implementation for companies growth, and advancing our healthcare industry through technological breakthroughs. #AIinnovation #healthcareinnovation #healhtech #AI #startupnation
-